05/06/2026
What are CPCs and why could they be key to cure?
Dr Sandrine Roulland explains CPCs – commonly known as “Cancer Precursor Cells” which are becoming increasingly referred to as “Cancer Persistor Cells.”
These are a small group of cells that can remain in the body after treatment, which researchers believe may be one of the reasons follicular lymphoma can come back later.
Understanding these cells – what they look like, how they survive and how they behave – could help us find ways to stop relapse from happening in the first place.
That’s why this area of research matters so much.
At the Follicular Lymphoma Foundation, we’re supporting research to better understand CPCs – because targeting the cells that drive relapse is a critical step towards cure.